APOBEC3B and neoplasm: Last, low levels of human A3B expressed constitutively from the endogenous Rosa26 promotor cause no overt tumor phenotypes and no detectable APOBEC signature mutations.16 The latter two studies call-to-question the role of A3B in human tumor pathology.